We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Healthcare spending in the U.S. totaled almost $2 trillion in 2005, or $6,697 per person, with total spending for prescription drugs in 2005 pegged at $200.7 billion, the Centers for Medicare & Medicaid Services (CMS) reported.
PhRMA is tentatively supporting the Centers for Medicare & Medicaid Services’ (CMS) proposal to collect and share prescription drug plan data, but is concerned that the agency may overreach by using the information to compare different products.
Healthcare providers have to consider what the Centers for Medicare & Medicaid Services (CMS) will reimburse them for when deciding to purchase new medical devices.
PhRMA is tentatively supporting the Centers for Medicare & Medicaid Services’ (CMS) proposal to collect and share prescription drug plan data, but is concerned that the agency may overreach by using the information to compare different products.
A key committee is recommending that the Centers for Medicare & Medicaid Services (CMS) soften a controversial proposal to require clinical trials it covers to enroll representatives of the populations Medicare serves.
Generics could see wider use in Medicare Part D next year, as many of the new drug plans participating in the program substitute generics for their brand equivalents, according to a new side-by-side examination of the 2006 and 2007 programs by the Kaiser Family Foundation.
Generics could see wider use in Medicare Part D next year, as many of the new drug plans participating in the program substitute generics for their brand equivalents, according to a new side-by-side examination of the 2006 and 2007 programs by the Kaiser Family Foundation.
With new reimbursement rates for oxygen and oxygen equipment, the Centers for Medicare & Medicaid Services (CMS) has "significantly increased the payment amounts for oxygen from what it had originally proposed," the American Association for Homecare says. Read More
A new study has found that a noninvasive, computer-based test is at least as effective as an invasive and more expensive test in predicting a patient’s risk of sudden cardiac death.
The device industry is not likely to quietly accept cuts to imaging services under the final rule for the Medicare physician fee schedule (MPFS), according to AdvaMed President and CEO Stephen Ubl.